Individual Response Monitoring Assay (IRMA) – Standardization of Personalized Multiplex Biomarker Quantification
Konferenz: MikroSystemTechnik 2019 - Kongress
28.10.2019 - 30.10.2019 in Berlin, Deutschland
Tagungsband: MikroSystemTechnik Kongress 2019
Seiten: 2Sprache: EnglischTyp: PDF
Persönliche VDE-Mitglieder erhalten auf diesen Artikel 10% Rabatt
Autoren:
Juelg, Peter; Specht, Mara; Meyer, Martin; Schlenker, Franziska (Hahn-Schickard, Freiburg, Germany)
Kipf, Elena; von Stetten, Felix; Zengerle, Roland; Paust, Nils; Lehnert, Michael; Hutzenlaub, Tobias (Hahn-Schickard, Freiburg & Laboratory for MEMS Applications, IMTEK-Department of Microsystems Engineering, University of Freiburg, Germany)
Baensch, Felix; Neumann, Stefan (GNWI Gesellschaft für naturwissenschaftliche Informatik mbH, Germany)
Fillies, Marion; Kirschner-Schwabe, Renate; Groeneveld-Krentz, Stefanie; Eckert, Cornelia (Charité Universitätsmedizin Berlin, Germany)
Inhalt:
The emerging demand for personalized cancer diagnostics is in conflict with an increasing challenge for assay standardization by regulatory authorities. Minimal residual disease (MRD) monitoring of acute lymphoblastic leukemia (ALL) patients is such an assay [1]. Here, patient-individual primer designs and PCR optimizations make assay standardization challenging. The IRMA approach combines three technological advances to provide a solution for standardized and patient-individual PCR assays: (1) Software assisted assay design (2) Modular assay technology (3) Microfluidic standardization.